Clinical Trials News
Find useful articles and information related to clinical trials and health to help you make informed and empowered decisions about participating in a trial and your overall health.
Filter by articles related to:
Article related to:
Chronic Conditions
Clinical Trials
Mayo Clinic Leads Trial Study for Type 2 Diabetes
With 96 million pre-diabetic and 37 million type 2 diabetic Americans, the urgency to treat the chronic condition is of national importance. Aligning with November as National Diabetes Month, the Mayo Clinic is stepping up efforts to recruit individuals for a clinical device trial. The device being tested helps diabetics treat the condition and monitor glucose levels without the needle sticks. The test is being conducted nationwide.
Article related to:
Technology
Clinical Trials
Chronic Conditions
AI-Discovered Drug to Treat ALS Begins Clinical Trials
Biotech company Verge Genomics leveraged AI to discover a drug to treat ALS. Verge used a proprietary AI platform to analyze DNA, RNA, and protein profile data to identify a new target and corresponding drug to treat ALS. Not only did AI accelerate research and development timelines, this was among the first instances where both the target and drug that affects the target have been wholly identified by AI. The drug is now in phase 1 clinical trials.
Article related to:
Clinical Trials
Patient Experience
Diversity
Walmart Enters Clinical Trials Market
Walmart launched its Walmart Healthcare Research Institute, leveraging its scale and retail footprint to join rivals CVS and Walgreens in the growing clinical trials space. In a press statement, Walmart outlined its goal "to increase community access to healthcare research that may lead to safer, higher quality and more equitable healthcare." To advance the initiative, Walmart has identified a range of study partners, including clinical research organizations, pharmaceutical companies, and leading medical academic institutions.
Article related to:
Cancer
Genomics
New Cancer Treatment Shows Precision Medicine's Impact
A recent FDA accelerated approval for a drug that targets a cancer-causing genetic mutation demonstrates the effectiveness of precision medicine. “Precision medicine” is treatment based on a patient’s biology and can help doctors identify treatments that are more individualized and specific to a patient. The new drug, Retevmo, has proven effective on thyroid, lung, pancreatic, colon, and other cancers for patients with the genetic alteration called RET fusion, even if those patients had prior treatment that was ineffective for them.
Article related to:
Chronic Conditions
Clinical Trials
Collaborative of Top Research Institutions to Conduct Long COVID Clinical Trials
As millions of people have been affected by lingering symptoms from COVID, a newly formed collaboration of top U.S. research institutions will study how long COVID impacts the immune system, cognitive function, and other processes. It will also try to identify the root cause of how COVID and viruses in general can "drive chronic disease." Researchers will eventually conduct clinical trials on antiviral and other treatments to combat long COVID's effects and improve vaccines.
Article related to:
Clinical Trials
Mental Health
Chronic Conditions
New Clinical Study Shows This Number of Steps May Slow Dementia
A UK clinical study of over 78,000 participants tracked for nearly seven years demonstrated that between 3,800 and 9,800 steps per day were associated with a lower risk of dementia by 25%-50%. While a quicker pace of 40 steps per minute was linked to 57% lower risk, the largest reduction in dementia risk came from brisk walking of 112 steps per minute for 30 minutes a day. Ultimately, the researchers concluded that the intensity of the steps matters more than the number of steps.
Article related to:
Genomics
Clinical Trials
Diversity
NIH's All of Us Bus Tours US to Help Speed Up and Diversify Clinical Trials Research
The National Institutes of Health has taken its All of Us Research Program on the road with a bus tour, seeking to enroll participants who reflect the diversity of the U.S. The program is building the world's most diverse health database, intended to help speed up medical research and make it more inclusive. The All of Us Research Program’s Journey tour bus will travel around the country to various events and clinics to onboard potential participants.
Article related to:
Cancer
Clinical Trials
Diversity
Cancer Clinical Trials Rebound After Pandemic Slowdown
After a steep COVID slowdown, cancer treatment research has revived. A recent oncology study showed the number of newly activated trials and total participants have now surpassed pre-pandemic levels. Of note, the study revealed that non-whites were more commonly taken off trials—due to disease progression, toxicity, or patient request—than whites.
Article related to:
Diversity
Clinical Trials
Closing the Diversity Gap in Health Research
Public and private efforts are aligning to address the diversity gap in medical research and clinical trials. Guidance from the FDA has charted a path toward better representation in medicine. The health care industry can improve diversity and overall medical outcomes through committed leadership, innovative use of data, research and trials designed with diversity in mind, and continuous education efforts.
Article related to:
Diversity
Mental Health
Cancer
Clinical Trials
Women Are Still Underrepresented in Clinical Trials
A recent study highlighted the gender gap and how progress in enrolling more women in clinical trials has slowed. The study showed that while the U.S. population is 51% female, only 41% of trial participants are female. In certain medical areas where women are disproportionately impacted, such as cancer, cardiovascular, and psychiatric disorders, the gender gap is even greater.
Read the full story at Washington Post
(May require subscription)
Article related to:
Diversity
Clinical Trials
Walgreens Launches Clinical Trial Business As FDA Seeks Diversity Of Patients
Walgreens is entering the clinical trials business with an emphasis on diversity. With 1 in 5 drugs having varied responses among different ethnicities, the need for diverse representation in medical research is critical. Walgreens plans to use its nationwide network of physical and digital stores in its effort to reach diverse participants.
(May require subscription)
Article related to:
Chronic Conditions
Clinical Trials
Mayo Clinic Leads Trial Study for Type 2 Diabetes
With 96 million pre-diabetic and 37 million type 2 diabetic Americans, the urgency to treat the chronic condition is of national importance. Aligning with November as National Diabetes Month, the Mayo Clinic is stepping up efforts to recruit individuals for a clinical device trial. The device being tested helps diabetics treat the condition and monitor glucose levels without the needle sticks. The test is being conducted nationwide.
With 96 million pre-diabetic and 37 million type 2 diabetic Americans, the urgency to treat the chronic condition is of national importance. Aligning with November as National Diabetes Month, the Mayo Clinic is stepping up efforts to recruit individuals for a clinical device trial. The device being tested helps diabetics treat the condition and monitor glucose levels without the needle sticks. The test is being conducted nationwide.
Article related to:
Technology
Clinical Trials
Chronic Conditions
AI-Discovered Drug to Treat ALS Begins Clinical Trials
Biotech company Verge Genomics leveraged AI to discover a drug to treat ALS. Verge used a proprietary AI platform to analyze DNA, RNA, and protein profile data to identify a new target and corresponding drug to treat ALS. Not only did AI accelerate research and development timelines, this was among the first instances where both the target and drug that affects the target have been wholly identified by AI. The drug is now in phase 1 clinical trials.
Biotech company Verge Genomics leveraged AI to discover a drug to treat ALS. Verge used a proprietary AI platform to analyze DNA, RNA, and protein profile data to identify a new target and corresponding drug to treat ALS. Not only did AI accelerate research and development timelines, this was among the first instances where both the target and drug that affects the target have been wholly identified by AI. The drug is now in phase 1 clinical trials.
Article related to:
Clinical Trials
Patient Experience
Diversity
Walmart Enters Clinical Trials Market
Walmart launched its Walmart Healthcare Research Institute, leveraging its scale and retail footprint to join rivals CVS and Walgreens in the growing clinical trials space. In a press statement, Walmart outlined its goal "to increase community access to healthcare research that may lead to safer, higher quality and more equitable healthcare." To advance the initiative, Walmart has identified a range of study partners, including clinical research organizations, pharmaceutical companies, and leading medical academic institutions.
Walmart launched its Walmart Healthcare Research Institute, leveraging its scale and retail footprint to join rivals CVS and Walgreens in the growing clinical trials space. In a press statement, Walmart outlined its goal "to increase community access to healthcare research that may lead to safer, higher quality and more equitable healthcare." To advance the initiative, Walmart has identified a range of study partners, including clinical research organizations, pharmaceutical companies, and leading medical academic institutions.
Article related to:
Cancer
Genomics
New Cancer Treatment Shows Precision Medicine's Impact
A recent FDA accelerated approval for a drug that targets a cancer-causing genetic mutation demonstrates the effectiveness of precision medicine. “Precision medicine” is treatment based on a patient’s biology and can help doctors identify treatments that are more individualized and specific to a patient. The new drug, Retevmo, has proven effective on thyroid, lung, pancreatic, colon, and other cancers for patients with the genetic alteration called RET fusion, even if those patients had prior treatment that was ineffective for them.
Article related to:
Chronic Conditions
Clinical Trials
Collaborative of Top Research Institutions to Conduct Long COVID Clinical Trials
As millions of people have been affected by lingering symptoms from COVID, a newly formed collaboration of top U.S. research institutions will study how long COVID impacts the immune system, cognitive function, and other processes. It will also try to identify the root cause of how COVID and viruses in general can "drive chronic disease." Researchers will eventually conduct clinical trials on antiviral and other treatments to combat long COVID's effects and improve vaccines.
Article related to:
Clinical Trials
Mental Health
Chronic Conditions
New Clinical Study Shows This Number of Steps May Slow Dementia
A UK clinical study of over 78,000 participants tracked for nearly seven years demonstrated that between 3,800 and 9,800 steps per day were associated with a lower risk of dementia by 25%-50%. While a quicker pace of 40 steps per minute was linked to 57% lower risk, the largest reduction in dementia risk came from brisk walking of 112 steps per minute for 30 minutes a day. Ultimately, the researchers concluded that the intensity of the steps matters more than the number of steps.
Article related to:
Genomics
Clinical Trials
Diversity
NIH's All of Us Bus Tours US to Help Speed Up and Diversify Clinical Trials Research
The National Institutes of Health has taken its All of Us Research Program on the road with a bus tour, seeking to enroll participants who reflect the diversity of the U.S. The program is building the world's most diverse health database, intended to help speed up medical research and make it more inclusive. The All of Us Research Program’s Journey tour bus will travel around the country to various events and clinics to onboard potential participants.
Article related to:
Cancer
Clinical Trials
Diversity
Cancer Clinical Trials Rebound After Pandemic Slowdown
After a steep COVID slowdown, cancer treatment research has revived. A recent oncology study showed the number of newly activated trials and total participants have now surpassed pre-pandemic levels. Of note, the study revealed that non-whites were more commonly taken off trials—due to disease progression, toxicity, or patient request—than whites.
Article related to:
Diversity
Clinical Trials
Closing the Diversity Gap in Health Research
Public and private efforts are aligning to address the diversity gap in medical research and clinical trials. Guidance from the FDA has charted a path toward better representation in medicine. The health care industry can improve diversity and overall medical outcomes through committed leadership, innovative use of data, research and trials designed with diversity in mind, and continuous education efforts.
Article related to:
Diversity
Mental Health
Cancer
Clinical Trials
Women Are Still Underrepresented in Clinical Trials
A recent study highlighted the gender gap and how progress in enrolling more women in clinical trials has slowed. The study showed that while the U.S. population is 51% female, only 41% of trial participants are female. In certain medical areas where women are disproportionately impacted, such as cancer, cardiovascular, and psychiatric disorders, the gender gap is even greater.
Read the full story at Washington Post
(May require subscription)
Article related to:
Diversity
Clinical Trials
Walgreens Launches Clinical Trial Business As FDA Seeks Diversity Of Patients
Walgreens is entering the clinical trials business with an emphasis on diversity. With 1 in 5 drugs having varied responses among different ethnicities, the need for diverse representation in medical research is critical. Walgreens plans to use its nationwide network of physical and digital stores in its effort to reach diverse participants.
(May require subscription)
Our website uses cookies, as almost all websites do, to help provide you with the best experience we can. You can learn more about all the cookies and the information we collect by reading our Privacy Policy.
